Clinical trials

Health 10-10-2017

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.

EU agency OK’d 39 cancer drugs without evidence they work, study shows

The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).

Brexit 24-05-2017

UK biotech boasts Europe’s best pipeline as Brexit looms

Britain's biotech sector boasts the strongest new drug pipeline in Europe but industry leaders say it needs continued access to global talent, funding and regulatory clarity to thrive in the future - all of which could be jeopardised by Brexit.

Development Policy 04-05-2017

African Union EU rep: ‘Africa shouldn’t just be a spectator to global decisions’

The African Unions EU representative, Ajay Bramdeo, told EURACTIV Germany that plans for a Marshall Plan for Africa are fundamentally good but warned that the continent needs to be the focus and that healthcare must be the priority.

03-05-2017

Allowing patients to choose could save billions

The Commission’s recent musings on the social dimension of Europe touches on common drug pricing among member states. But it misses out on solutions for faster access to medicine, Fred Roeder.

Economy & Jobs 15-03-2017

The Commission’s innovation confusion

Unless the European Commission changes its attitude, the innovation gap between Europe and the US will likely increase, and it could be overtaken soon by China, with dire consequences for living standards, warns Philip Stevens.

Health 07-02-2017

Rare cancers: A headache for policymakers

The complexity of diagnosing and treating rare forms of cancers like sarcomas can be addressed by a multi-level approach and better coordination among member states, insist experts in the field.

Health 02-02-2017

Lawmakers warn EU pharma industry about drug pricing

Pressure is mounting on pharmaceutical companies to reconsider the way they do business by refocusing their efforts on meeting patient needs and health outcomes rather than their own profits.

Health 19-01-2017

Germany votes to ease access to medical marijuana

The German Bundestag today (19 January) unanimously passed legislation granting seriously ill patients easier access to medical marijuana. EURACTIV Germany reports.

Health 11-01-2017

Tattoos could pose health risk says new Commission report

Ink used in tattoo parlours can contain low-purity pigments that are not meant to be applied to the skin and may pose a health risk, according to a European Commission report. EURACTIV Spain reports.

Health 03-11-2016

Alzheimer Europe chief: Holistic approach needed to tackle dementia

Alzheimer’s disease and other forms of dementia remain underdiagnosed in most European countries, Jean Georges told EURACTIV.

Health 21-10-2016

Andriukaitis: Health Technology Assessment will make EU healthcare ‘sustainable’

EXCLUSIVE / National healthcare systems should embrace the digital era and use Health Technology Assessment (HTA) to become truly sustainable and cost-effective, European Commissioner for Health and Food Safety Vytenis Andriukaitis told EURACTIV.com in an interview.

Health 01-09-2016

EU’s sunbed safety assessment clouded by bias

An upcoming assessment by a European Commission committee on the risks of UV radiation and sunbeds is hamstrung by in-built bias and a failure to comprehensively address all the issues, warns Frank Harbusch.

Development Policy 23-08-2016

Brexit casts doubt over Uganda development project on lung disease

The UK's vote to leave the European Union has come at a crucial moment in the development of an international medical project that throws into sharp relief the state of flux Brexit has cast over collaborative research, says Jack Barton.

Health 01-08-2016

EU drugs agency to unveil results on ‘early medicines’ project this week

The European Medicines Agency (EMA) will this week publish the much-awaited results of a pilot project on the early marketing authorisation of drugs, EURACTIV has learnt.

Health 26-07-2016

Pharma expert: new ‘value added medicines’ offer cheaper, customised treatment

A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com

Health 13-06-2016

New medical devices rules should avoid ‘unnecessary’ red tape, industry says

The implementation of new rules on medical devices should avoid extra burdens and unnecessary bureaucracy, health industry officials have told EURACTIV.com.

EU project hopes to phase out animal-testing

When chemicals are considered too dangerous to be tested on humans, animals have long been the answer to some scientific quandaries. The EU project ToxRisk will act as Europe's flagship for safety assessments that do not require the use of animals. EURACTIV Germany reports.

Supermarket
Agrifood 20-11-2015

Food industry wants common science principles to boost trust

The EU's food and drinks industry has developed a set of principles for research conduct that will apply to the sector.

Ben Goldacre
Health 22-10-2014

Ben Goldacre: Pharma industry has destroyed its own reputation

EXCLUSIVE: The great tragedy for the pharmaceutical industry is that it keeps denying that it lobbies against transparency in clinical trials, says Ben Goldacre.

Pills

EU Ombudsman: Clinical trials face new transparency challenges

Medical researchers in Europe are facing new challenges over access to clinical trials data, according to the European Ombudsman Emily O'Reilly.

31 drugs intended to treat cancer were approved by the European Medicines Agency (EMA) over the past three years. 2011 [Interpharma/Flickr]

Cancer research at a crossroads in Germany

A new EU regulation is meant to make clinical trials easier and more transparent, a pivotal tool in the fight against deadly diseases like cancer. But researchers in Germany warn that the country may lose its role as a leader in international medicine. EURACTIV Germany reports.

Pills
Health 11-06-2014

Growing concerns over medicines agency’s proposed rules for transparency

A growing number of health and consumer advocacy organisations are urging the European Medicines Agency (EMA) to rethink its proposals to restrict the viewing of clinical trial results ahead of a board meeting Thursday (12 June).

Pills
Health 21-05-2014

EU Ombudsman worried over lack of transparency at medicines agency

The European Ombudsman, Emily O'Reilly, has written to the European Medicines Agency (EMA), expressing concern about a significant change of clinical trial data transparency policy.